NewsHK
The rapid adoption of GLP-1 weight-loss drugs is reshaping demand across medical aesthetics.
The Botox maker reported a business boost tied to what clinicians and patients call "Ozempic face," the colloquial term for facial volume loss that can accompany rapid weight reduction from GLP-1 therapies.
The company has expressed hope that continued GLP-1 uptake will fuel further demand for its treatments.
GLP-1 side effects meet the aesthetics cycle Ozempic face is an unwanted outcome for patients, but for aesthetics providers it reads as a referral driver.
Keep reading